Anika Therapeutics
ANIK
ANIK
156 hedge funds and large institutions have $515M invested in Anika Therapeutics in 2017 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 53 increasing their positions, 50 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
6% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 50
4% less capital invested
Capital invested by funds: $539M → $515M (-$24M)
1% less funds holding
Funds holding: 158 → 156 (-2)
Holders
156
Holding in Top 10
2
Calls
$1.62M
Puts
$1.25M
Top Buyers
| 1 | +$77.6M | |
| 2 | +$30.4M | |
| 3 | +$7.39M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$6.51M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$5.53M |
Top Sellers
| 1 | -$9.46M | |
| 2 | -$4.14M | |
| 3 | -$2.89M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.34M |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$2.31M |